On Tuesday, Citi restated a Neutral stance on Palantir Technologies Inc . (NYSE: NYSE:PLTR), maintaining a $28.00 price target for the company's stock. The firm acknowledged... On Tuesday, Mizuho ...
(Reuters) - Billionaire venture capitalist Peter Thiel has joined AbCellera Biologics Inc's board of directors, the Canadian antibody therapy developer said on Thursday. Thiel, ...